Fundraising FoxNantkwest
1 known investors
Find your way into Nantkwest
Sign up to see every warm intro you have to Nantkwest
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nantkwest team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ImmunityBio develops investigational immunotherapies that activate both innate and adaptive immune responses—stimulating NK cells, T cells, macrophages, and dendritic cells—to treat cancer and infectious diseases. The company works on cell therapies and potential cancer vaccines intended to reduce reliance on high-dose chemotherapy.
Investors · 1
Founder mafia
3 people who came through Nantkwest went on to found or lead other companies.
Frequently asked questions
- What does Nantkwest do?
- ImmunityBio develops investigational immunotherapies that activate both innate and adaptive immune responses—stimulating NK cells, T cells, macrophages, and dendritic cells—to treat cancer and infectious diseases. The company works on cell therapies and potential cancer vaccines intended to reduce reliance on high-dose chemotherapy.
- Who are Nantkwest's investors?
- Nantkwest's investors include Avoro Capital Advisors.